Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study - Wikidata - wikimedia - TriplyDB

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

http://www.wikidata.org/entity/Q28195282

about

A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity Hydrogen sulfide prodrugs-a review Prevention of anti-inflammatory drug-induced gastrointestinal damage: benefits and risks of therapeutic strategies The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor An economic model of long-term use of celecoxib in patients with osteoarthritis A comparison of cost effectiveness using data from randomized trials or actual clinical practice: selective cox-2 inhibitors as an example Anti-inflammatory effects of celecoxib in rat lungs with smoke-induced emphysema.Systematic review with meta-analysis: the gastrointestinal benefits of COX-2 selective inhibitors with concomitant use of low-dose aspirin.Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial.GI-REASONS: a novel 6-month, prospective, randomized, open-label, blinded endpoint (PROBE) trial Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials.Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis--an expert consensus addressing benefits as well as gastrointestinal and cardiovascular risks A review of the gastrointestinal safety data--a gastroenterologist's perspective.Patient benefit-risk in arthritis--a rheumatologist's perspective.Cost-effectiveness analyses of osteoarthritis oral therapies: a systematic review.Nonsteroidal anti-inflammatory drugs and upper and lower gastrointestinal mucosal damage.Safety of nonsteroidal antiinflammatory drugs in patients with cardiovascular disease.Relative cardiovascular and gastrointestinal safety of non-selective non-steroidal anti-inflammatory drugs versus cyclo-oxygenase-2 inhibitors: implications for clinical practice.Celecoxib for osteoarthritis.Myocardial Infarction and Its Association with the Use of Nonselective NSAIDs: A Nested Case-Control and Time-to-Event Analysis.The cycloxygenase 2 (COX-2) story: it's time to explain, not inflame.Comparison of gastroduodenal ulcer incidence in healthy Japanese subjects taking celecoxib or loxoprofen evaluated by endoscopy: a placebo-controlled, double-blind 2-week study.Efficacy and safety of celecoxib in chinese patients with ankylosing spondylitis: a 6-week randomized, double-blinded study with 6-week open-label extension treatment Effects of selective cyclooxygenase-2 and nonselective cyclooxygenase inhibition on myocardial function and perfusion Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example.Efficacy and safety of celecoxib compared with placebo and etodolac for acute postoperative pain: a multicenter, double-blind, randomized, parallel-group, controlled trial An evidence-based update on nonsteroidal anti-inflammatory drugs.Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk.Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs?Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.Antineuropathic and antinociceptive drugs combination in patients with chronic low back pain: a systematic review Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity.Duloxetine in the management of chronic musculoskeletal pain Network Meta-Analysis Comparing Relatively Selective COX-2 Inhibitors Versus Coxibs for the Prevention of NSAID-Induced Gastrointestinal Injury.Non-steroidal anti-inflammatory drug-induced cardiovascular adverse events: a meta-analysis.Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review.Effects of postoperative administration of celecoxib on pain management in patients after total knee arthroplasty: study protocol for an open-label randomized controlled trial.Minimizing risks of NSAIDs: cardiovascular, gastrointestinal and renal.Implants for total hip arthroplasty.

P2860

Q24615651-9624B123-443D-43E3-8AB8-06E4E126C68D Q26865084-A2DDEAC2-426D-4D86-8273-99691CD05F40 Q28200569-B7901E21-5461-46BC-B77B-0AD5B18F1715 Q28217400-C8D5E49D-33BE-4403-91EA-13B06FD54B7F Q28218005-3360D0AF-3A89-4356-9A6D-0F15B0E5F650 Q28472098-EE812C36-DFC5-4777-8E4F-2C92C65D22CA Q29346992-66815CB9-C9FC-475D-B0A7-2E473A8B6F8F Q30248439-3C3D7A2F-DBAA-4851-ABCF-10880A3BA4B6 Q30430170-536DA4D3-4A2A-4193-BEBD-BDF476857FDC Q30497323-CAAE41E9-2914-4FF0-8A78-643931EAB36C Q30537237-74F19693-9547-453D-B51A-08DA49E25A8D Q30540294-1051FCE1-D319-4BDB-B29D-4D4072EB068F Q30629677-F2F87B87-B6D4-494A-BFED-340137D1FBE6 Q33560647-3FC061AB-02F6-40FB-BD43-AF8631FFB249 Q33803037-5EA1E022-2895-4F3F-A817-590DE910FF8A Q34384075-5E5B456B-69CA-4695-97EF-837EE964B7F0 Q34387174-0750B394-6245-46C5-908E-08C533FBE88D Q34474985-BFF6CE3D-54C9-4DE1-99A2-C8DFE92E73DA Q34556831-3C64D3AA-B384-44E5-BD43-4E2358C9540F Q34557021-600042A1-00B0-407E-9B00-4E1FCE8BF0DF Q34589334-633238A0-701A-44A1-A942-BCDC6E808986 Q34636574-D93B8BA8-004E-42CD-BA9E-15BB6B25507C Q34646087-9F5E37A6-1B98-4827-97DC-54A559BA75C5 Q34705364-80C81883-5715-4A58-9270-EB0F971E1D22 Q34798660-52D35F95-E63B-4D79-88C1-F90BE53CA455 Q35045666-78238CB8-3DAC-47C4-B398-A1B61487D8F8 Q35181952-33BE574C-E839-4ED1-9BE1-5FCD30517699 Q35758411-63E21E7A-A21B-4858-82DA-23927E8448E7 Q35769055-01CF9A0E-2E15-494D-8E89-FA75AA57792E Q35942177-E6C350AA-DF80-4EAF-8FDD-4A1B17618416 Q35954561-8DA29F4C-079D-411D-A66F-19438CE92CA1 Q35955249-7A849B54-738F-4CCD-9795-04C8709F773A Q36001198-B6C9B72D-ED0B-4D9B-90F9-21DADA2D3B1C Q36071024-46DF1A90-815F-45AF-B94D-C9939C8F1FE3 Q36195392-E2595C67-7734-4288-8D88-3820C2EF5A11 Q36233306-C08413F3-EC1D-45EB-9208-8014524AC422 Q36246550-EBA62398-9E11-478D-95C0-101D6EC21984 Q36493653-77FA45A0-AEBB-49CE-BB68-E91672163344 Q36673018-2DD01AE2-75F9-4BF7-9613-63478276BBDA Q36728860-B0166DE6-8584-4806-BF24-CB1BCDAB02FA

P2860

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

http://www.wikidata.org/entity/Q28195282

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@ast

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@en

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@nl

type

label

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@ast

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@en

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@nl

prefLabel

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@ast

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@en

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@nl

P1433

Q28195282-74D62BE4-FAD2-43E4-8F15-9D8111DD3ACB

P1476

Q28195282-61A1437A-58F4-434D-8BB9-ABE8712AAC93

P2093

Q28195282-4B1DB59A-6CBC-4B01-ADEB-E02875923230

Q28195282-4C592B5A-686C-4AFE-B277-9B69E2C16BC1

Q28195282-6958EFB6-28FF-4486-A8FB-57C345C2D1F0

Q28195282-72754F90-5FA7-4DD5-AE77-37D4A265967A

Q28195282-AF47A6A7-C6EF-4932-9ACE-1BDB4B83FE6C

Q28195282-B974B428-1ADB-4F61-866E-F3BDB0F25D14

Q28195282-C1534524-E7CF-419D-8E9E-8EED746DC8E4

Q28195282-D2132818-38E9-4BE5-9186-E7985DEAE9F8

Q28195282-D25B03C0-9286-4E3D-B06B-9E909180B911

Q28195282-EA2441F6-ECA8-4BC0-974C-1553034F62FA

P304

Q28195282-5522D4BC-554F-4F52-83A5-51B8E3755DDC

P31

Q28195282-8F43379E-DF08-44EC-AF16-1FA9FFD26C93

P356

Q28195282-5A0AE835-0CDE-4473-9512-C7B0BFEB26A2

P407

Q28195282-F82E4F95-D791-47E4-AFB4-C957BCAD748D

P433

Q28195282-E694B925-531E-47BA-B2BB-63050D036101

P478

Q28195282-1457F1B9-1858-42FC-9836-BCCC201B5F32

P50

Q28195282-0359472B-CB61-40B6-80A6-C650D9B4C56B

Q28195282-BEB913A9-0C42-46AE-B75E-A24E178329EE

P577

Q28195282-0EB6C50C-AFEC-4F36-BFB3-9FB268A4DF7C

P5875

Q28195282-1629E7F1-A830-47AC-9A63-8E57DC26FA69

P698

Q28195282-8DBB5FF6-E430-4F9E-909C-6E94E95B110E

P921

Q28195282-74E325D8-A6ED-4E2F-A4DF-41E1DBAB8C65

Q28195282-CCE78088-690E-4616-A697-1907DE6E6B33

Q28195282-EA40D0EE-0E9D-4778-AA05-6E21C358ED38

P356

J.AMJMED.2005.09.054

P1433

The American Journal of Medicine

P1476

Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study

@en

P2093

Alfonso E Bello

http://www.w3.org/2001/XMLSchema#string

Carl Wallemark

http://www.w3.org/2001/XMLSchema#string

Glenn M Eisen

http://www.w3.org/2001/XMLSchema#string

Gurkirpal Singh

http://www.w3.org/2001/XMLSchema#string

Jay L Goldstein

http://www.w3.org/2001/XMLSchema#string

John G Fort

http://www.w3.org/2001/XMLSchema#string

Lilia Andrade-Ortega

http://www.w3.org/2001/XMLSchema#string

Naurang M Agrawal

http://www.w3.org/2001/XMLSchema#string

Patrick S Hanrahan

http://www.w3.org/2001/XMLSchema#string

William F Stenson

http://www.w3.org/2001/XMLSchema#string

P304

255-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJMED.2005.09.054

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

George Triadafilopoulos

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7287692

http://www.w3.org/2001/XMLSchema#string

P698

16490472

http://www.w3.org/2001/XMLSchema#string

P921